DSIP is a nine-residue peptide investigated through animal sleep physiology and small human experiments, with inconsistent evidence for meaningful sleep benefit.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Experimental sleep-related nonapeptide
Delta sleep-inducing peptide, usually abbreviated DSIP, has the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Early investigators isolated sleep-associated material from rabbit blood dialysate and compared it with synthetic peptide. The historical name reflects those experiments; it does not itself establish a reliable sleep-inducing effect in people.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
DSIP research initially measured electroencephalographic activity and sleep behavior rather than demonstrating a specific receptor pathway. Changes in delta activity or sleep timing can describe an experimental response without identifying its molecular cause. The cited studies leave the mechanism and physiological significance incompletely resolved.
The 1978 sequence and synthesis study assessed synthetic DSIP in rabbits and reported changes in sleep-associated EEG patterns. Comparisons with modified sequences addressed chemical specificity, but animal electrophysiology alone cannot establish clinical sleep quality. [1]
A double-blind crossover experiment in six healthy volunteers explored immediate and delayed sleep effects. Its small sample and short observation period make it an exploratory physiological study rather than persuasive evidence for treating insomnia. [2]
A controlled study in 16 people with chronic insomnia found some objective differences, including sleep efficiency and onset. The authors characterized statistically significant effects as weak and potentially partly attributable to incidental changes in the placebo group. [3]
Study topics describe the cited models, not established benefits of this catalog material.
Human studies exist, but they are small and do not supply a strong, reproducible clinical efficacy foundation. Objective sleep recordings, subjective sleep quality, and daytime experience are distinct outcomes. A difference in one measurement should not be generalized into broad claims of restorative sleep.
The literature cited here does not establish sustained benefit, broad applicability, or long-term safety. Historical trial preparations and experimental conditions cannot be assumed equivalent to WYZ Labs materials. The peptide's suggestive name should not substitute for adequately controlled contemporary studies with meaningful clinical endpoints.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Chemical characterization and rabbit EEG experiments.
Double-blind crossover experiment in six healthy volunteers.
Sixteen participants; weak effects with possible placebo-group contribution.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAOther single compounds in the collection.
Metabolic Research
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
Metabolic Research
MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling and skeletal-muscle adaptation, with experimental interventions supported mainly by cell and animal evidence.
Dermal Research
GHK-Cu is a copper complex of glycyl-histidyl-lysine studied for its effects on extracellular-matrix production and remodeling in experimental tissue-repair systems.
